The current report contributes to the understanding of the stereoselectivity of the chiral dirhodium(II) carboxylate catalysts derived from N-protected amino acid ligands. Investigating the possible effect of ligand stereo-purity on catalyst structure and enantioselectivity was carried out. This was justified through a new X-ray crystal structure for Rh2(S,S,S,R-PTTL)4 diastereomer.
Introduction
Chiral dirhodium(II) complexes are currently renowned as catalysts that can effectively drive a broad spectrum of reactions with superior levels of chemo-, regio-and stereo-selectivity [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Their remarkable selectivity has reached a stage where they can function as powerful tools in building up value added molecules with complex structures [7, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] .
Out of the large dirhodium(II) catalyst family and by following different approaches for catalyst design, several highly enantioselective dirhodium(II) carboxylate catalysts have been reported to date [13, [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] . Our research group, for example, has recently reported a novel approach for the design of dirhodium(II) tetracarboxylate complexes derived from S-amino acid ligands [35, 36, 45] . This approach is founded on tailoring the steric influences of the overall catalyst structure through reducing the local symmetry of the ligand's N-heterocyclic tether. The application of this new approach led to the uncovering of Rh2(Stert PTTL)4 ( Figure 1 ) as a new member to the dirhodium(II) family with outstanding selectivity in asymmetric cyclopropanation reactions [35] . However, despite the number of successful approaches used for catalyst design, limited evidence is still available on how the four chiral carboxylate ligands within the dirhodium(II) carboxylate framework tailor the product chirality at the catalyst active center [46] . At the heart of all enantioselectivities observed with chiral dirhodium(II) carboxylate complexes is, of course, the individual chirality of ligands. In the case of published X-ray crystal structures of 2 of 13 various solvated adducts of Rh2(S-PTTL)4 [47, 48] , Rh2(Stert PTTL)4 [35] , Rh2(S-NTTL)4 [49] , Rh2(S-PTAD)4 [35] and others [35, 50, 51] , the incorporation of a ligand stereogenic center can be seen to give rise to a "chiral binding pocket" or "chiral crown cavity". Figure 2 [47, 48] depicts the two most important features that are responsible for the establishment of the chiral binding pocket in Rh2(S-PTTL)4 and related complexes; C-C single bond torsion (carboxylate carbon to α-carbon bond) which lies so as to direct the C-N bond in a clockwise twist towards the carbene binding pocket (Figure 2a ), and N-C bond torsion so as to allow docking of the adjacent N-phthaloyl units featuring O ... CH closest contacts of an alternating σ/π nature (Figure 2c ). Visually, the overall effect is to cause an alternation of the positions of the eight oxygen atoms of the N-phthaloyl units, which thus reside at high and low positions around the rim of the crown cavity as a result (Figure 2b ) [35] . Based on these observed features, the use of optically pure ligands in the process of catalyst preparation is essential for the construction of the symmetric chiral cavity and for acheiving extremely reliable enantioselective catalysis [52] . This is because, the inclusion of a ligand with an opposite absolute configuration will result in the interruption of the symmetry of the chiral pocket. As a consequence, in 2005, Hashimoto explored the racemization free N-phthaloylation of tertleucine and reported that it can be achieved in refluxing toluene/TEA mixture with minimal racemization [52] . While in 2012, Charette reported the same N-protection reaction using different Lamino acids in refluxing DMF for achieving enantiomerically pure N-protected-L-amino acid ligands [41] . Furthermore, the racemization free N- 1,8-[41,53] and N-2,3-naphthaloylation [54] of L-amino acids were claimed to take place under the same conditions. Another report indicated that racemization free N-protection of amino acids was possible in refluxing acetic acid [55] . These later reports did not, however, provide any quantitative information about the degree of racemization that accompanied the N-protection of L-amino acids under the employed reaction conditions and no racemization was assumed to take place.
To the best of our knowledge, there are no reports to indicate the issues/benefits that might accompany the use of enantiomerically impure chiral ligand in the process of chiral dirhodium(II) catalyst preparation. Therefore, the trigger of the current research was to point out any aspects that can correlate the enantio-purity of the chiral carboxylate ligand used to the structure of the corresponding catalyst and to highlight any implications that this might have on catalyst enantioselectivity. We were inspired by the work done by Fox [40] and Charette [41] , independently, as they both explored the interruption of the chiral cavity symmetry by substituting one of the four carboxylate ligands with an achiral ligand. Screening results revealed that interrupting the cavity framework has, indeed, a beneficial impact on the asymmetric induction of these complexes.
Results and Discussion
The current work started when PTTL ligand was synthesised three times using three different reaction solvents namely acetic acid, DMF and toluene/TEA, under refluxing conditions leading to chiral ligands with different degrees of enantiopurity (ee values of the obtained PTTLAA, PTTLDMF and PTTLTol/TEA ligand were found to be 78%, 86% and >99% ee, respectively). These prepared ligands were further used for the synthesis of three dirhodium(II) complexes, Rh2(PTTLAA)4, Rh2(PTTLDMF)4 and Rh2(PTTLTol/TEA)4, respectively at which, the obtained complexes were expected to vary in their degree of stereo-purity.
When Rh2(PTTLAA)4 was crystallized from methanol/water in an open flask, three types of X-ray quality crystals were observed and isolated. The first were green prismatic crystals and, they were [47, 48] , the inherent weakness of the cavity walls is apparent in the obtained aquated Rh2(S-PTTL)4 structure(s) (Figure 3a, b ). This is owing to the obvious absence of strong interactions between adjacent N-phthaloyl units. is given in (a) to highlight the significantly different conformation of one of the ligands that results in "reversal" of the chirality of the crown cavity.
In fact, there are a number of structural features of major significance that comes to light through the detailed analysis of this newly determined X-ray structure of Rh2(PTTL)4 which can be correlated to the performance of this class of dirhodium(II) complexes in asymmetric catalysis. From the current structure and in light of the recent advances in the field, it is evident that the previously reported flattened rectangular shape structure of the crown cavity [47, 48] is subject to substantial variations which appear to be influenced by the identity of the axial bound ligand and, at least in the solid state, by the intermolecular interactions including crystal packing forces. Whilst of irregular shape, the crown cavity of the current structure(s) (Figure 3a [47, 48] .
Beyond the overall shape of the irregular crown cavities described above, the mono aquated complex, [Rh2(S-PTTL)4.(H2O)], features a partial "reversal" of its chiral nature ( Figure 3a ). Whilst all four amino acid derived ligands maintain their S-stereogenic carbon centres, the C-N bond from this carbon centre in one ligand is close to being aligned with the axial coordination site of the Rh centre (circled in Figure 3a ). This is in contrast with the clockwise twist reported for [Rh2(S-PTTL)4.(EtOAc)] [47, 48] and other related complexes [35, [49] [50] [51] . As a result, the daisy-chain type docking of the Nphthaloyl units around the cavity seen in [Rh2(S-PTTL)4.(EtOAc)], which gives the cavity its main chiral feature (Figure 2c ), is not only disrupted but is, in fact, partially reversed. This was most apparent in the formation of an edge (C-H)-face π-stacking of the involved N-phthaloyl unit with an adjacent ligand and a partial loss in regularity of the alternating locations of the oxygen atoms around the cavity compared to Rh2(S-PTTL)4.(EtOAc) structure ( Figure 3a ).
When Rh2(PTTLAA)4 was crystallized from anhydrous methanol under an argon atmosphere, we were able to isolate crystals of a methanol solvated adduct and determine the X-ray crystal structure. This showed the complex to be the disolvated species [Rh2(S-PTTL)4.(MeOH)2].(MeOH)3/2. This complex also exhibited a distorted crown cavity where one of the N-heterocycles features a reverse twist akin to the mono-aquated adduct [Rh2(S-PTTL)4.(H2O)] describe above. In the solid state, there are two crystallographically independent molecules each having this structure, despite having different endo-cavity arrangements of hydrogen bonded MeOH molecules in addition to the axially coordinated solvent.
The ability of Rh2(S-PTTL)4 to have axial ligands bonded to the Rh centre shrouded by the crown cavity, as well as the more sterically encumbered Rh centre was, indeed, evident through the obtained diaquated structure (Figure 3b ). This fact was also previously observed through many other complexes from the same family [35, [49] [50] [51] including Rh2(S-PTAD)4 which carry the bulkiest adamantyl groups at the ligands' α-positions [35] . This observation can be also applied to carbene ligands during asymmetric catalysis which contradicts with the major assumption of Fox mechanistic study for Rh2(S-PTTL)4 in asymmetric cyclopropanations [47, 48] . Fox assumed that only the Rh centre within the chiral crown cavity is accessible by the incoming substrate while the other is shielded by the four tert-butyl substituents of the PTTL ligands. This prior held assumption may not be valid and should be revised.
In addition to the aquated form of Rh2(S-PTTL)4 described above, we succeeded to identify another plate shaped green crystalline form from our methanol/water crystallized sample of Rh2(PTTLAA)4. These crystals were shown to be comprised of the catalyst diastereomeric form, [Rh2(S,S,S,R-PTTL)4(MeOH)2.].MeOH.H2O (Figure 4 ) by X-ray structure determination. In addition to identifying at least one of the forms in which the R-amino acid impurity manifests itself, an analysis of the structural details is also instructive here as it allows speculation as to the possible enantioselectivity that this impurity would achieve under catalytic conditions. This analysis is of major importance if the level of impurity is significant. The S,S,S,R-form features Rh bound methanol molecules at each axial coordination site and an α,α,α,β-conformation of the ligands, whereby the three N-phthaloyl units of the S-amino acid derived ligands form a partial crown cavity and the unique R-amino acid derived ligand faces the other axial binding site. Two of the N-phthaloyl groups forming the partial crown cavity exhibit conformations very similar to those in [Rh2(S-PTTL)4(EtOAc)] [47, 48] and the predominant ligand types found in the aquated species described above (circled in Figure 4a ). The third N-phthaloyl unit lacks the clockwise twist noted previously. This overall motif affords a partial cavity chirality (shown schematically in Figure 4a ) of the same nature to the enantiomerically pure S,S,S,S-diastereomer of the complex (shown schematically in Figure 2 ). Based on previous results from Fox [40] and Charette [41] related to the functionality of the α,α,α,β-conformation, it can be hypothesized that the obtained S,S,S,R-form may still achieve a good degree of enantioselectivity and, importantly, towards the same product as obtained with the dominant S,S,S,S-form. Whilst we cannot disprove the presence of further diastereomeric forms existing in the same sample of Rh2(PTTLAA)4 at this stage, we have highlighted the potential advantage of the enantiomeric ligand purity assimilating as a minor component within the S,S,S,Rdiastereomeric form rather than segregating as the R,R,R,R-enantiomer which will strictly afford the opposite enantioselectivity to the S,S,S,S-form.
At this stage and based on the obtained X-ray crystal structures, we decided to further examine whether deviation from linearity exist which might give an indication on the functionality of the S,S,S,R-diastereomeric form.
If the catalyst system contains a non-enantiopure chiral ligand with an enantiomeric excess eeligand, an enantiomerically enriched product with an enantiomeric excess of eeprod can be obtained. The calculation of the enantiomeric excess of the product (eemax) for an enantiopure ligand can easily be calculated if one assumes that the enantiomers of the ligand (in the catalyst) act independently. The proportionality between eeligand and eeprod in the below equation allows the eemax value to be calculated (ee values between 0 and 1). In other words, the expected enantiomeric excess of the reaction product should be proportional to the ee value of the chiral ligand in the catalyst (Linearity). However, in the case of multiligand catalysts (which is the case of chiral dirhodium(II) tetracarboxylate catalysts), the above equation generally is no longer obeyed. This is because diastereomeric species are produced which are impossible to generate from the enantiopure ligands. In fact, some deviation from linearity may be observed (non-Linear effect) [60] .
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In addition to the three prepared versions of Rh2(PTTL)4, five more dirhodium(II) complexes were prepared of which each complex was prepared three times using ligands obtained from different reaction solvents, namely acetic acid, DMF and toluene/TEA (Scheme 1 and 2). Scheme 1 illustrates the effect of changing the reaction solvent on the extent of racemization in the prepared Nprotected amino acid ligands. It is obvious from the HPLC results that different degrees of racemization were introduced with the alteration of the reaction solvent. It is also clear from the results that the goal of obtaining ligands with minimal racemization can be readily achieved by employing toluene/TEA as a reaction solvent which is in agreement with the previous report by Hashimoto for the preparation of the PTTL ligand [52] . By the utilization of this reaction condition, the degree of racemization for the prepared N-protected amino acids is limited and kept to a minimum, however, an exception to this was found in the case of N-1,2-naphthaloyl phenylalanine (NTPA), at which, around 15% racemization took place (Scheme 1). At this point, all the prepared catalysts were subjected to catalysis and to facilitate the investigation, we employed our previously developed user-friendly one-pot cyclopropanation of styrene with Meldrum's acid. In this reaction, a phenylidonium ylides is generated and used in situ [53, 56] . All reactions were carried out at room temperature in DCM as reaction solvent and results are illustrated in Figure 5 . As expected, the obtained results did show some deviation from linearity for all catalysts used, however, Rh2(PTTL)4, Rh2(1,2-NTTL)4, Rh2(1,2-NTPA)4 and Rh2(1,2-NTLU)4 catalysts showed positive deviation, while Rh2(1,2-NTTR)4 and Rh2(1,2-NTTY)4 showed negative deviation.
The obserevd positive effects may link to the presence of a partial crown structure similar to the S,S,S,R diastereomer observed for Rh2(PTTL)4. While in the other cases where negtive deviation was observed, other solution species may have arisen and resulted in diffenent influences. These other influences are untestable at this stage and beyond the scope of this report. 
Materials and Methods

Chemicals
All starting materials and reagents were purchased from Sigma-Aldrich, Acros Organics and Tokyo Chemical Industry Co., Ltd (TCI) and used without any further purification. All solvents were of HPLC grade and dried and distilled immediately prior to use. All reactions were performed using oven dried glassware and flame dried under vacuum prior to use. TLC was performed using Sigma-Aldrich pre-coated silica gel 60 F254 aluminium support (20 x 20 cm, layer thickness 0.2 mm) and spots were visualized by either using UV light (254 nm). Preparative TLC purifications were performed using Sigma-Aldrich pre-coated silica gel 60 F254 glass support (20 x 20 cm, 0.25 mm layer thickness). Column chromatography was carried out on silica gel 60 (130-270 mesh ASTM, Sigma-Aldrich) using the specified eluent compositions. Rh2(OAc)4 was purchased from Strem Chemicals.
Instruments
Melting points were measured on Stuart-SMP10 melting point apparatus and are uncorrected. Optical rotations were measured using Perkin-Elmer 341 polarimeter at the sodium D line (589 nm) and reported as [α]D 25 in g/100 mL concentration (c) and in solvents indicated . IR spectroscopic measurements were carried out on PerkinElmer TravelIR FT-IR spectrometer and reported in units of cm -1 . NMR spectra were recorded on Varian 400-MR and Varian Inova-500 spectrometers at room temperature. Mass Spectrometric analysis was recorded on Finnigen mat LCQ MS/MS ESI spectrometer and AB MDS Sciex 4800 MALDI-TOF-TOF mass analyser.
HPLC analysis
The HPLC analysis was carried out at 25 o C using a Prominence Shimadzu System that consists of LC-20AD solvent delivery unit, SPD-M20A photodiode-array detector, SIL-20AHT auto sampler and CTO-20A column oven. For data processing, LabSolutions data managing software, version 5.54 SP2 was utilized. Chiralpak® IB (0.46 mm x 250 mm), Chiralpak® IG (0.46mm x 250mm) and Chiralpak® ID (0.46 mm x 250 mm) were obtained from Daicel Chiral Technologies. HPLC-grade nhexane, ethyl acetate and 2-propanol were obtained from Scharlau Chemie S.A.
X-Ray crystallography for dirhodium(II) complexes
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X-ray quality crystals of the dirhodium(II) complexes were obtained dissolving the pure complex in the relevant solvent (for [Rh2(S-PTTL)4(H2O)][Rh2(S-PTTL)4(H2O)2].5H2O green prismatic crystals from MeOH/water, [Rh2(S,S,S,R-PTTL)4(MeOH)2].MeOH.H2O green plate shaped crystals from MeOH/water and for [Rh2(S-PTTL)4(MeOH)2].(MeOH)3/2 green prismatic crystals from anhydrous MeOH). The resulting solutions were subjected to sonication and Pasteur pipette filtration followed by slow evaporation of the solvent to yield crystals. Data were collected at -173 °C on crystals mounted on a Hampton Scientific cryoloop at the MX1 or MX2 beamlines, Australian Synchrotron, Victoria. [57] The structures were solved by direct methods with SHELXS-97, refined using full-matrix least-squares routines against F 2 with SHELXL-97 [58] , and visualised using X-SEED [59] . All non-hydrogen atoms were anisotropically refined, while, all hydrogen atoms were positioned in calculated locations and refined using a riding model with fixed C-H distances of 0.95 Å (sp 2 CH), 0.99 Å (CH2), 0.98 Å (CH3). The thermal parameters of all hydrogen atoms were estimated as Uiso(H) = 1.2Ueq(C) except for CH3 where Uiso(H) = 1.5Ueq(C).
CCDC-1834045-1834047 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via https://www.ccdc.cam.ac.uk/structures/.
General procedure for ligand preparation
A mixture of 1,2-naphthalic anhydride (1.1 equiv.) and the L-amino acid (1 equiv.) in either anhydrous acetic acid, DMF or toluene/TEA (0.1 equiv.) was heated to reflux under nitrogen atmosphere overnight. After that time, the reaction was worked up according to one of the below procedures to afford the corresponding reaction product.
Reaction workup procedures a) When using acetic acid as solvent
The reaction solvent was evaporated in vacuo and the residue was directly purified on silica gel column chromatography using ethyl acetate: n-hexane as an eluent to afford the desired product.
b) When using DMF as solvent
The reaction mixture was diluted in water and extracted with ethyl acetate twice. The organic layer was washed with water three times, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was then purified on silica gel column chromatography using ethyl acetate: nhexane as an eluent to afford the desired product.
c) When using Toluene/TEA as solvent
The mixture was diluted with ethyl acetate, washed twice with 0.1M hydrochloric acid solution, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was then purified on silica gel column chromatography using ethyl acetate: n-hexane as an eluent to afford the desired product.
N-(Phthaloyl)-tert-Leucine (PTTL)
Phthalic anhydride (0.5 g, 3.38 mmol), L-tert-Leucine (0.402 g, 3.07 mmol); white solid (0.746 g, 93%); mp 154 o C. Spectroscopic data were consistent with the previously published literature [52] . Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with 0.1% TFA, 0.25 mL/min, 254 nm, τ1 = 16.0 min, τ2 = 17.0 min. (1,2-NTTL) 1,2-Naphthalic anhydride (0.650 g, 3.28 mmol), L-tert-Leucine (0.391 g, 2.98 mmol); yellow oil (0.825 g, 89%). Spectroscopic data were consistent with the previously published literature [36] . Conditions for chiral HPLC trace: Chiralpak® IB column, 10% 2-propanol in n-hexane (v/v%) with 0.1% TFA, 0.25 mL/min, 254 nm, τ1 = 22.5 min, τ2 = 24.5 min. (1,2-NTPA) 1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Phenylalanine (0.35 g, 2.10 mmol); pale yellow solid (0.65 g, 89%); mp 182 o C. Spectroscopic data were consistent with the previously published literature [36] . Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with 0.1% TFA, 0.5 mL/min, 254 nm, τ1 = 40.0 min, τ2 = 44.0 min. (1,2-Naphthaloyl)-Leucine (1,2-NTLU) 1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Leucine (0.3 g, 2.29 mmol); pale yellow solid (0.64 g, 90%); mp 138-139 o C. Spectroscopic data were consistent with the previously published literature [36] . Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with 0.1% TFA; 0.25 mL/min, 254 nm, τ1 = 56.0 min, τ2 = 61.0 min. (1,2-NTTR) 1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Tryptophan (0.47 g, 2.29 mmol); yellow solid (0.83 g, 85%); mp 238-239 o C. Spectroscopic data were consistent with the previously published literature [36] . Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with 0.1% TFA; 0.25 mL/min, 254 nm, τ1 = 110.0 min, τ2 = 131.0 min.
N-(1,2-Naphthaloyl)-tert-Leucine
N-(1,2-Naphthaloyl)-Phenylalanine
N-
N-(1,2-Naphthaloyl)-Tryptophan
N-(1,2-Naphthaloyl)-Tyrosine (1,2-NTTY)
1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Tyrosine (0.42 g, 2.29 mmol); yellow solid (0.74 g, 90%); mp 248-249 o C. Spectroscopic data were consistent with the previously published literature [36] . Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with 0.1% TFA, 0.5 mL/min, 254 nm, τ1 = 52.5 min, τ2 = 51.0 min.
General procedure for ligand exchange [36, 52] A mixture of the prepared carboxylic acid ligand (6 equiv.) and dirhodium(II) tetraacetate (Rh2(OAc)4, 1 equiv.) in dry chlorobenzene was refluxed for 24 h under nitrogen atmosphere using a Soxhlet extractor fitted with a thimble containing dry mixture of Na2CO3 and sand (1:1) for trapping the eliminated acetic acid molecules. After that time, the solvent was evaporated in vacuo and the residue was re-dissolved in DCM, washed with saturated NaHCO3 solution, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The green residue was then purified by means of silica gel column chromatography using ethyl acetate: n-hexane as mobile phase. Spectroscopic data of all prepared complexes were consistent with the previously published literature [36, 52] .
General procedure for cyclopropanation [53, 56] 2,2-Dimethyl-1,3-dioxane-4,6-dione (1 equiv.) was dissolved in dry dichloromethane and stirred with (diacetoxy)iodobenzene (1.4 equiv.), aluminium oxide (2.3 equiv.), 4Å molecular sieves and dirhodium(II) catalyst (0.01 equiv.) under nitrogen atmosphere for 5 min. After that time, Styrene (10 equiv.) was added and the mixture was stirred for 2 h. The reaction was then terminated by filtration through Celite® and concentrated in vacuo. The obtained residue was then purified by means of preparative TLC. Spectroscopic data were consistent with the previously published literature [53, 56] . Enantiomeric excess of the cyclopropane product was determined by chiral HPLC analysis. Conditions for chiral HPLC trace: Chiralpak® IG column, 10% ethyl acetate in n-hexane (v/v%); 1 mL/min, 254 nm, τ1 = 25 min, τ2 = 33 min.
Conclusions
The current report contributes to the structural understanding of the reactivity and selectivity of dirhodium(II) carboxylate complexes derived from N-protected amino acid ligands. This contribution was through investigating the effect of ligand stereo-purity on the catalyst enantioselectivity. In conclusion, the use of partially resolved chiral ligand can produce some perturbations generated by the formation of diastereomeric complexes and such perturbations cannot be deducted from the sole behaviour of the catalyst prepared from the enantio-impure ligand.
This was confirmed by the observation of Rh2(S,S,S,R-PTTL)4 diastereomer structure. The complex showed that it adapts an α,α,α,β-conformation in solid state with the three S-ligands poiting to one side while the R-ligand is alone on the other. By having a partial chiral cavity, the observed complex was anticipated to perform catalysis in a similar way to its diasteromer Rh2(S-PTTL)4. The obtained catalysis results did show deviation from linearity and did reflect the anticipated effect caused by the presence of this type of diastereomer on the enantioselectivity of some dirhodium(II) carboxylate catalysts. In this regard, further research is currently being carried out in our group aiming for a more systematic study and endeavouring to get further insights into this interesting topic. Results will be reported in due course.
This report has also heightened awareness of subtle conformational variations that these complexes can adapt during the various phases of their catalytic cycles. This awareness evolved through the discovery of new Rh2(S-PTTL)4 structures including its mono-and di-aquated adducts, as well as its di-methanol adduct.
Generally by drawing attention to the added complexity of these important structural issues, we can acknowledge that dirhodium(II) carboxylate catalysts are highly fluxional structures and more than one catalyst conformation might be present in solution at the same time. The energetics of these different conformers can change throughout the catalytic process and different conformers may have different energy barriers in productive processes involved in the catalytic cycle. Hence, the different conformrs of the catalyst will contribute to the overall catalytic process to different extents proportional to their relative abundance in solution. 
